Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.29B |
| Enterprise Value | 10.4B |
| P/E Ratio | 277.87 |
| PEG Ratio | 6.42 |
| Price/Sales Ratio | 20.32 |
| Price/Book Ratio | 16.89 |
| Enterprise/Revenue | 20.63 |
| Enterprise/EBITDA | 180.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 704.16M |
| Revenue/Share | 1.91 |
| Gross Profit | 704.16M |
| EBITDA | 59.85M |
| Net Income | 22.23M |
| Diluted EPS | 0.05 |
Balance Sheet
| Total Cash | 194.9M |
| Total Cash/Share | 0.48 |
| Total Debt | 434.93M |
| Total Debt/Equity | 0.47 |
| Current Ratio | 1.36 |
| Book Value Per Share | 2.3 |
Price History
| 52-Week Change | 141.68 |
| 52-Week High | 41.63 |
| 52-Week Low | 15.41 |
| Moving Average 50 Days | 33.88 |
| Moving Average 200 Days | 28.2 |
Statistics
| Average Volume | 10.07M |
| Shares Outstanding | 405.71M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.21 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
